As a result of the fact that CD33 mutations also change the immunological functions of peripheral monocytes (Bradshaw et al., 2013), the CD33 mutation-altered peripheral immune system may contribute to AD pathogenesis to some extent, as do altered microglia functions. Here, CD33 is linked to Alzheimer disease.